JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Differences in Keloid and Hypertrophic Scar Treatment Patterns by Race

Published online August 21, 2026

Dear Editor, Keloids are a dermatologic condition with high recurrence rates and variable treatment success. Racial disparities can play a crucia...

read more
Current Considerations for Laser and Energy-Based Devices in Transgender Patient Care

Published online August 19, 2026

Physical characteristics that can contribute to gender dysphoria in transgender patients, including facial and body hair, hormonal acne...

read more
Topical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report

Published online August 17, 2026

Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular disorder characterized by violaceous, reticulated skin t...

read more
Review of the Efficacy of Topical 5-Alpha Reductase Inhibitors for the Treatment of Androgenetic Alopecia

Published online August 13, 2026

Androgenetic alopecia (AGA) is a non-scarring alopecia triggered by an inherited follicular sensitivity to dihydrotestosterone (DHT) an...

read more
Hidradenitis Suppurativa in Psoriasis Patients Treated With Biologics

Published online July 20, 2026

To the Editor, While biologic medications are frequently used to treat inflammatory skin diseases, patients have experienced paradoxical skin dis...

read more
Reddit for Redness: A Cross-Sectional Analysis of the r/Rosacea Forum

Published online July 28, 2026

Patients are increasingly turning to social media for disease/treatment advice and support. 1 This has varying benefits 2 but involve...

read more
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Published online July 27, 2026

Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patien...

read more
Improvement of Rosacea With Tirzepatide: A Case Report

Published online July 28, 2026

Tirzepatide is a dual glucagon-like pedtide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) agonist and is primarily used ...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

F around and Find Out: Failing Forward, IL-17F in Focus, and Finding New Treatment Paradigms and Friendships through Industry Collaborations

| Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Tae Oh For too long, the therapeutic ladder in hidradenitis suppurativa has often looked less like a ladder and more like an uneven mound: try this, fail that,…

Molluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment

| Featured Articles, Latest News, Medical Derm | No Comments
Navigating Pediatric Molluscum Contagiosum: Updated Consensus and Therapeutic Strategies  Have you caught up on this essential publication from the Journal of Drugs in Dermatology (JDD) yet? Pediatric molluscum contagiosum (MC)…
Journal of Drugs in Dermatology JDD featuring Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex

| Acne, Featured Articles, Latest News | No Comments
New Insights on CAB Gel Performance Across Diverse Acne Demographics  This is a must-read article from the Journal of Drugs in Dermatology (JDD) that every practicing clinician will want on…

Recombinant Zoster Vaccine Reduces 3-Year Cardiovascular Risk: Insights From a Multi-Centered Database

| Featured Articles, Latest News, Medical Derm | No Comments
From the Vault: Uncovering the Broader Systemic and Cardiovascular Benefits of Shingles Immunization While dermatologists routinely counsel patients on preventing the painful cutaneous and neurological sequelae of herpes zoster, the…

Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol

| Featured Articles, Latest News, Psoriasis | No Comments
Evaluating Dietary Strategies as Adjunctive Interventions in Inflammatory Skin Disease As patients increasingly seek non-pharmacologic interventions to support their psoriasis treatment, interest in dietary modifications has surged. However, clinical guidance…
Journal of Drugs in Dermatology JDD featuring The State of Sunscreens in the US: Caveat Emptor

The State of Sunscreens in the US: Caveat Emptor

| Featured Articles, Latest News, Photoprotection | No Comments
From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor  With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

JDD Podcast – Aspiring Higher: Research Tales from Pfizer Grant Awardees

| Featured Articles, Featured Podcast, JDD Highlights, JDD Higlights, JDD in the Media, Podcast Highlights, The Latest | No Comments
The JDD Podcast, Ask the Investigator, has released six episodes highlighting research tales from Pfizer Grant awardees. In each episode, Dr. Adam Friedman discusses the grant awardees journey. See below and…
Tune In

Follow Us